Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02136758 · ClinicalTrials.gov registry record · NA

Cardiovascular Risk Clinic

A NA study, sponsored by Windber Research Institute.

Terminated
Registry status
NA
Development phase
207
Enrollment target

NCT02136758: Clinical Trial NA study, sponsored by Windber Research Institute.

NCT02136758 is a NA study that was terminated before completion, run by Windber Research Institute. The registered enrollment target is 207 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02136758, a NA study, was terminated before completion, sponsored by Windber Research Institute.

TERMINATED
Registry status
NA
Development phase
207 participants
Enrollment target

Study Summary

This study was a prospective, randomized trial designed to investigate the efficacy of moderate lifestyle modification for improving the clinical status of patients with coronary artery disease or patients with risk factors that promote coronary artery disease.

Primary Outcome

Change in BMI

Interventions

  • BEHAVIORAL CRC lifestyle modification program

Trial Details

FieldValue
Enrollment Target 207 participants
Start Date 2009-04
Est. Completion 2013-07
Phase NA
Windber Research Institute

2 total trials

Why NCT02136758 stopped before completion

NCT02136758 is an interventional study that assigns participants to a tested intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 1 intervention - of which CRC lifestyle modification program is the first listed.

NCT02136758 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02136758 about?

NCT02136758 is a clinical study titled "Cardiovascular Risk Clinic". This study was a prospective, randomized trial designed to investigate the efficacy of moderate lifestyle modification for improving the clinical status of patients with coronary artery disease or patients with risk factors that promote coronary artery disease.

What is the current status of trial NCT02136758?

This trial is currently terminated. It is a NA study. The enrollment target is 207 participants. The study started on 2009-04. Estimated completion is 2013-07.

What interventions are being tested in trial NCT02136758?

The interventions under investigation include: CRC lifestyle modification program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02136758?

This trial is sponsored by Windber Research Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02136758's enrollment target sits among peer trials

207 499th of 2000 higher than 1,502 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04353778 · 207 participants · Phase 1

    Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV

  • NCT05875805 · 207 participants · NA

    A Telehealth Advance Care Planning Intervention

  • NCT06254950 · 207 participants · Phase 2

    A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

  • NCT06904274 · 207 participants · Phase 3

    Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02136758, the US trial registry maintained by the National Library of Medicine. NCT02136758 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.